DIHYDRONAPHTHO[2,3-b]BENZOFURAN DERIVATIVE
The present invention provides a dihydronaphtho[2,3-b]benzofuran derivative represented by formula (1) that can be applied to the prevention and treatment of NTRK fusion-gene-positive cancers (such as non-small-cell lung cancer), a pharmacologically acceptable salt thereof, solvates of these, and a...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French Japanese |
Published |
04.05.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a dihydronaphtho[2,3-b]benzofuran derivative represented by formula (1) that can be applied to the prevention and treatment of NTRK fusion-gene-positive cancers (such as non-small-cell lung cancer), a pharmacologically acceptable salt thereof, solvates of these, and a pharmaceutical composition containing these as an active ingredient.
La présente invention concerne un dérivé de dihydronaphtho [2,3-b]benzofurane représenté par la formule (1) et pouvant être utilisé dans la prévention et le traitement des cancers du gène de fusion NTRK (tel que le cancer du poumon non à petites cellules), un sel pharmacologiquement acceptable de celui-ci, des solvates de ceux-ci, et une composition pharmaceutique contenant ceux-ci en tant que principe actif.
本発明は、NTRK融合遺伝子陽性のがん(非小細胞肺がんなど)の予防および治療へ適用できる、式(1)で表されるジヒドロナフト[2,3-b]ベンゾフラン誘導体化合物、その薬学的に許容され得る塩、またはそれらの溶媒和物、およびそれらを有効成分として含有する医薬組成物である。 |
---|---|
Bibliography: | Application Number: WO2016JP81988 |